PNH ALPHA Study
ALPHA: Phase III Long-term Data for Ravulizumab or Eculizumab With Add-on Danicopan or Placebo in Patients With PNH and cs-EVH

Released: December 14, 2023

Activity

Progress
1
Course Completed